Asset Base EnhancementAn updated 43-101 report shows a significant increase in both resource and reserve estimates, enhancing the company's asset base.
Financial FlexibilitySigma seems to have ample financial flexibility, allowing it to remain positive even with lower spodumene prices.
Operational PerformanceThe company is experiencing improved dynamics in Q3, with tailwinds benefiting both the commodity and the company.